Last edition
News about "Indian Pharmacopoeia Commission"
IP 2026 Conclave Highlights Pharmacopoeial Standards for Pharma Quality
The Indian Pharmacopoeia Commission (IPC) strengthens industry preparedness for IP 2026 through awareness, capacity-building, stakeholder engagement, and adoption of pharmacopoeial standards for quality-assured medicines.
Indian Pharmacopoeia Commission | 11/06/2026 | By News Bureau
Indian Pharmacopoeia Commission (IPC) hosts the Indian Pharmacopoeia (IP) 2026 Scientific Conclave and Interactive Session, focusing on medicine quality, impurity standards, regulatory science, and patient safety.
Indian Pharmacopoeia Commission | 16/05/2026 | By News Bureau | 117
IPC Signs MoUs with PMBI and NIPER Hajipur to Enhance Drug Quality and Safety
IPC signs MoUs with PMBI and NIPER Hajipur to enhance drug quality, pharmacovigilance, research, safety of biologics and emerging therapies, and patient safety across India, including Jan Aushadhi Kendras.
Indian Pharmacopoeia Commission | 27/04/2026 | By News Bureau
IPC to Conduct 36th Pharmacovigilance Skill Development Programme in March 2026
The Indian Pharmacopoeia Commission (IPC), the National Coordination Centre (NCC) for the Pharmacovigilance Programme of India (PvPI), will organise the 36th Skill Development Programme (SDP) on Pharmacovigilance (PV) from March 9 to March 13, 2026. The programme will be conducted in online mode.
Indian Pharmacopoeia Commission | 29/12/2025 | By Darshana | 293
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy